Allogeneic Stem Cell Transplantation for Sickle Cell Disease

Current Opinion in Hematology - United States
doi 10.1097/moh.0000000000000282
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Shared Decision Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Hematopoietic Stem Cell Transplantation for Sickle Cell Disease: State of the Science

European Journal of Haematology
MedicineHematology
2014English

Allogeneic Hematopoietic Stem Cell Transplantation

Archives of Internal Medicine
2002English

Allogeneic Cellular and Autologous Stem Cell Therapy for Sickle Cell Disease: ‘Whom, When and How’

Bone Marrow Transplantation
TransplantationHematology
2011English

Reduced Toxicity Conditioning (RTC) and Allogeneic Stem Cell Transplantation (AlloSCT) for Pediatric Sickle Cell Disease (SCD): Significant Improvement in Physical Functioning

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Allogeneic Stem Cell Transplantation for Acquired Pure Red Cell Aplasia

American Journal of Hematology
Hematology
2019English

Relapse After Allogeneic Stem Cell Transplantation

Expert Review of Hematology
Hematology
2010English

Allogeneic Stem Cell Transplantation for Children With Sickle Cell Disease Achieves Quality of Life Similar to Normal Children and Is Cost Effective

Biology of Blood and Marrow Transplantation
TransplantationHematology
2014English

Allogeneic Stem Cell Transplantation for Korean PNH Patients

Biology of Blood and Marrow Transplantation
TransplantationHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy